| Availability: | |
|---|---|
INCI Name | Pueraria Lobata Root Extract, Saccharomyces/Zinc Ferment, Lactobacillus Ferment, etc. |
Colour | Yellow-Brown to Brown |
Appearance | Liquid |
PH | 3.5–6.5 |
Recommended Dosage | 1%–10% |
Storage | Store at room temperature, dry, sealed, and away from light. |
WActive®Fermecleanin operates through a multi-targeted approach to address oily and acne-prone skin. It inhibits 5α-reductase—the enzyme converting testosterone to dihydrotestosterone (DHT) that stimulates sebaceous gland activity—and ACC (acetyl-CoA carboxylase), a key regulator of fatty acid synthesis, effectively reducing lipid production at its source. In vitro, 2% Fermecleanin reduced 5α-reductase activity to 13.82 ng/mg, comparable to isotretinoin (14.47 ng/mg) and Zinc PCA (14.48 ng/mg).
Antimicrobial & Anti-inflammatory: At 1% and 2% concentrations, Fermecleanin achieved approximately 51% inhibition of C. acnes, surpassing Zinc PCA (44%). It also reduced LPS-induced IL-6 expression by 15.93%, demonstrating superior anti-inflammatory activity compared to Zinc PCA (1.07% inhibition). In SZ95 sebocytes, 1% Fermecleanin significantly reduced FFA-induced lipid production, outperforming non-fermented Pueraria lobata extract—confirming that the dual-fermentation process enhances oil-control efficacy.
Clinical Performance (In Vivo): In a 28-day study, 5% WActive®Fermecleanin demonstrated both instant and sustained sebum control: significant reduction in facial sebum content at 1h and 2h post-application, and sustained efficacy at D14 and D28 versus placebo (###p < 0.001). Additionally, skin hydration (MMV) increased by 22.22% at D14 and 31.15% at D28—far exceeding placebo (3.04% and 5.86%). Erythema reduction was also greater than placebo, confirming soothing and barrier-repair benefits. These combined actions—sebum suppression, antimicrobial defense, inflammation reduction, and hydration—position WActive®Fermecleanin as a holistic, science-backed active for balancing and restoring compromised skin.